First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT – Get Free Report) was the target of a significant decline in short interest during the month of May. As of May 29th, there was short interest totaling 24,273 shares, a decline of 38.0% from the May 14th total of 39,179 shares. Based on an average trading volume of 24,573 shares, the short-interest ratio is currently 1.0 days. Currently, 0.2% of the company’s stock are sold short.
Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund
Large investors have recently modified their holdings of the business. High Point Wealth Management LLC purchased a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund during the fourth quarter worth about $26,000. Russell Investments Group Ltd. grew its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 7,900.0% during the third quarter. Russell Investments Group Ltd. now owns 160 shares of the company’s stock worth $29,000 after acquiring an additional 158 shares during the last quarter. Rossby Financial LCC grew its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 160.0% during the third quarter. Rossby Financial LCC now owns 169 shares of the company’s stock worth $31,000 after acquiring an additional 104 shares during the last quarter. AG Campbell Advisory LLC purchased a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund during the fourth quarter worth about $31,000. Finally, Cassaday & Co Wealth Management LLC purchased a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund during the first quarter worth about $34,000.
First Trust NYSE Arca Biotechnology Index Fund Stock Performance
Shares of FBT stock opened at $225.61 on Monday. First Trust NYSE Arca Biotechnology Index Fund has a fifty-two week low of $157.51 and a fifty-two week high of $229.39. The firm has a market capitalization of $2.55 billion, a price-to-earnings ratio of 21.72 and a beta of 0.68. The stock’s 50-day simple moving average is $211.19 and its 200-day simple moving average is $209.25.
About First Trust NYSE Arca Biotechnology Index Fund
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.
Featured Stories
- Five stocks we like better than First Trust NYSE Arca Biotechnology Index Fund
- 3 ETFs Giving Ready-Made Access to the Discounted International Small-Cap Space
- What to Expect From Q2 Earnings as Tech Strength Broadens
- Viasat’s Orbiting Profits: Space Force Jackpot?
- Robinhood Wants a Bigger Role in IPOs—Here’s Why It Matters
Receive News & Ratings for First Trust NYSE Arca Biotechnology Index Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for First Trust NYSE Arca Biotechnology Index Fund and related companies with MarketBeat.com's FREE daily email newsletter.
